Context Therapeutics Inc (CNTX)

1.97 -0.09 (-4.37%) USD  |  NASDAQ  |  Nov 13, 16:00
1.97 0.00 (0.00%) After-Hours: 20:00
More

Context Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for CNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to . Upgrade now.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

Collegium Pharmaceutical Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Palatin Technologies Inc Upgrade
iBio Inc Upgrade
Theriva Biologics Inc --